The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. - Steinberg MH; McCarthy WF; Castro O; Ballas SK; Armstrong FD; Smith W; Ataga K; Swerdlow P; Kutlar A; DeCastro L; Waclawiw MA (American journal of hematology, 2010)